Your browser doesn't support javascript.
loading
E(mu)-TCL1 mice represent a model for immunotherapeutic reversal of chronic lymphocytic leukemia-induced T-cell dysfunction.
Gorgun, Gullu; Ramsay, Alan G; Holderried, Tobias A W; Zahrieh, David; Le Dieu, Rifca; Liu, Fenglong; Quackenbush, John; Croce, Carlo M; Gribben, John G.
Affiliation
  • Gorgun G; Department of Medical Oncology, The Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
Proc Natl Acad Sci U S A ; 106(15): 6250-5, 2009 Apr 14.
Article in En | MEDLINE | ID: mdl-19332800
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes / Leukemia, Lymphocytic, Chronic, B-Cell / Proto-Oncogene Proteins / Disease Models, Animal / Immunotherapy Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Proc Natl Acad Sci U S A Year: 2009 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes / Leukemia, Lymphocytic, Chronic, B-Cell / Proto-Oncogene Proteins / Disease Models, Animal / Immunotherapy Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Proc Natl Acad Sci U S A Year: 2009 Document type: Article Affiliation country: United States Country of publication: United States